Literature DB >> 10457365

Positive and negative regulation of chondrogenesis by splice variants of PEBP2alphaA/CBFalpha1 in clonal mouse EC cells, ATDC5.

H Akiyama1, T Kanno, H Ito, A Terry, J Neil, Y Ito, T Nakamura.   

Abstract

The alphaA type of the alpha subunit of the polyomavirus enhancer binding protein 2 (PEBP2alphaA), also called the core binding factor alpha1 (CBFalpha1) or til-1, plays crucial roles in osteogenesis. Little is known, however, about the function of PEBP2alphaA in chondrogenesis. Here, we examined the role of PEBP2alphaA in chondrogenesis of clonal mouse embryonal carcinoma cells, ATDC5, which are committed as chondroprogenitors. We found that as ATDC5 cells condensed and formed cartilaginous nodules, PEBP2alphaA increased, and the level was maintained throughout the process of chondrocytic maturation. When an established dominant negative form of PEBP2alphaA was introduced in undifferentiated ATDC5 cells, the cellular condensation and the subsequent processes were inhibited. This inhibition was overcome with BMP-4 treatment, which increased the endogenous expression of PEBP2alphaA. Thus, the process of chondrogenesis is regulated by the level of PEBP2alphaA activity. Along with the wild-type PEBP2alphaA, a splice variant form, til-1 G2, is naturally expressed in ATDC5 cells. In luciferase reporter assays, til-1 G2 not only exhibited a limited ability to transactivate the osteocalcin promoter but also inhibited the activity achieved by the wild-type PEBP2alphaA. When til-1 G2 was overexpressed by stable transfection in undifferentiated ATDC5 cells, it inhibited the progression of chondrogenesis. Therefore, we conclude that PEBP2alphaA acts as a positive regulator of chondrogenesis, and that this positive effect may be finely tuned by the opposing effect of the til-1 G2 isoform. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457365     DOI: 10.1002/(SICI)1097-4652(199910)181:1<169::AID-JCP18>3.0.CO;2-5

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Comparative analysis of the two extremes of FLNB-mutated autosomal dominant disease spectrum: from clinical phenotypes to cellular and molecular findings.

Authors:  Qiming Xu; Nan Wu; Lijia Cui; Mao Lin; D Thirumal Kumar; C George Priya Doss; Zhihong Wu; Jianxiong Shen; Xiangjian Song; Guixing Qiu
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

2.  Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.

Authors:  Bau-Lin Huang; Sean M Brugger; Karen M Lyons
Journal:  J Biol Chem       Date:  2010-06-22       Impact factor: 5.157

3.  Calvarial cleidocraniodysplasia-like defects with ENU-induced Nell-1 deficiency.

Authors:  Xinli Zhang; Kang Ting; Dharmini Pathmanathan; Theodore Ko; Weiwei Chen; Feng Chen; Haofu Lee; Aaron W James; Ronald K Siu; Jia Shen; Cymbeline T Culiat; Chia Soo
Journal:  J Craniofac Surg       Date:  2012-01       Impact factor: 1.046

4.  Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation.

Authors:  Noboru Taniguchi; Beatriz Caramés; Emily Hsu; Stephanie Cherqui; Yasuhiko Kawakami; Martin Lotz
Journal:  J Biol Chem       Date:  2011-09-02       Impact factor: 5.157

5.  Runt-related transcription factor 1 regulates luteinized hormone-induced prostaglandin-endoperoxide synthase 2 expression in rat periovulatory granulosa cells.

Authors:  Jing Liu; Eun-Sil Park; Misung Jo
Journal:  Endocrinology       Date:  2009-04-02       Impact factor: 4.736

6.  Coordinated expression of matrix Gla protein is required during endochondral ossification for chondrocyte survival.

Authors:  B Newman; L I Gigout; L Sudre; M E Grant; G A Wallis
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

7.  Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling.

Authors:  Takashi Fujita; Yasutaka Azuma; Ryo Fukuyama; Yuji Hattori; Carolina Yoshida; Masao Koida; Kiyokazu Ogita; Toshihisa Komori
Journal:  J Cell Biol       Date:  2004-06-28       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.